Overview
Drug Abuse Screening Test – 10 item version (DAST-10) is a widely used, evidence-based screening tool designed to identify problematic drug use and related consequences, excluding alcohol and tobacco.
Originally developed by Dr. Harvey A. Skinner, DAST-10 is commonly used across mental health, addiction, and primary care settings to support early identification, clinical decision-making, and treatment planning.
What Does DAST-10 Measure?
DAST-10 assesses non-medical use of drugs and the impact of that use on an individual’s life over the past 12 months.
It focuses on:
- Drug-related behaviors
- Psychological and social consequences
- Loss of control related to drug use
- Problems caused by drug use
The tool provides a quick snapshot of severity, helping clinicians determine whether further assessment or intervention is needed.
Who Is DAST-10 For?
DAST-10 can be used with:
- Adolescents and adults
- Clients in mental health or addiction treatment
- Individuals in primary care or integrated care settings
It is commonly used by:
- Therapists and psychologists
- Psychiatrists
- Addiction counselors
- Primary care clinicians
- Community health programs
How DAST-10 Is Scored
DAST-10 consists of 10 yes/no questions related to drug use and its consequences.
Scoring Method
- Each “Yes” response scores 1 point
- Each “No” response scores 0 point
Total Score Range
- Minimum score: 0
- Minimum score: 10
Higher scores indicate greater severity of drug-related problems.
How DAST-10 Is Used
DAST-10 is commonly administered:
- During intake or initial assessment
- As part of routine screening
- To monitor changes in drug use over time
- To guide referrals or treatment planning
It is especially useful for identifying concerns early, even when substance use is not the client’s primary presenting issue.
Interpreting DAST-10 Scores
General interpretation guidelines include:
- 0: No problems reported
- 1–2: Low level of problems
- 3–5: Moderate level of problems
- 6–8: Substantial level of problems
- 9–10: Severe level of problems
Scores should always be interpreted within clinical context and followed by appropriate discussion or assessment.
Using DAST-10 on Our Platform
When delivered through our platform, DAST-10 enables clinicians to:
- Screen for drug-related concerns efficiently
- Identify emerging substance use issues early
- Track score changes over time
- Generate clear, readable reports
- Support treatment planning and clinical documentation
This enables clinicians to address substance use concerns consistently, ethically, and transparently.
Clinical Considerations
- DAST-10 is a screening tool, not a diagnostic measure
- It does not assess alcohol or tobacco use
- Follow-up assessment may be required for elevated scores
- Client honesty and therapeutic rapport are essential for accurate results
Skinner, H. A. (1982).
Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363–371.
Skinner, H. A., Samadi, S., Khan, S. B., & Crowley, L. (2024).
Drug Abuse Screening Test (DAST): First 40 Years and Future Developments.
The Canadian Journal of Addiction, 15(4), 6–13.
https://doi.org/10.1097/CXA.0000000000000222
Yudko, E., Lozhkina, O., & Fouts, A. (2007).
A comprehensive review of the psychometric properties of DAST.
Journal of Substance Abuse Treatment, 32(2), 189–198.
The DAST-10 (Drug Abuse Screening Test-10) is a validated, 10-item brief screening instrument used to identify clinically significant problems related to drug use, including illicit substances and the non-medical use of prescription medications. Unlike a simple “frequency” count, the DAST-10 focuses on the consequences of use—such as social, medical, or legal difficulties—making it a core tool for Measurement-Based Care (MBC) in behavioral health and primary care.
- Key Focus: It measures the impact of drug use on a client’s life over the past 12 months.
- Exclusion: The DAST-10 specifically excludes alcohol use, which is typically measured using the AUDIT.
The DAST-10 screens for the presence and severity of drug-related problems, ranging from loss of control and withdrawal symptoms to family disputes and guilt associated with drug use. By asking “Yes/No” questions about the impact of substance use, it helps clinicians differentiate between “experimental use” and “problematic use” that requires immediate clinical intervention.
The DAST-10 is scored by assigning one point for every “Yes” response (with the exception of Question 3, which is scored for a “No”), resulting in a total score between 0 and 10. Higher scores represent a greater intensity of drug-related problems and a higher likelihood of substance use disorder (SUD).
- Scoring Speed: Because it uses simple binary responses, the DAST-10 can be completed and scored in under two minutes, making it highly feasible for busy intake workflows.
A DAST-10 score of 3 or higher is the most widely recognized clinical threshold for a “positive” screen, indicating probable drug abuse or dependence and a clear need for a more comprehensive diagnostic evaluation. Standard severity ranges include:
- 0:o problems reported
- 1–2: N Low level of concern (Monitor)
- 3–5: Moderate level (Positive screen; further assessment warranted)
- 6–8: Substantial level (Intensive assessment recommended)
- 9–10: Severe level (Immediate intervention indicated)
No, the DAST-10 is a screening tool designed to flag “probable” abuse; a formal diagnosis of a Substance Use Disorder (SUD) must be made through a comprehensive clinical interview and a review of DSM-5 criteria. While a high score (6+) is a strong indicator of a disorder, it serves as a trigger for further diagnostic work rather than a standalone verdict.
The DAST-10 is used to screen for problems related to drugs (illicit and prescription), while the AUDIT (Alcohol Use Disorders Identification Test) is used exclusively for alcohol-related problems. Most high-performing clinics use both tools together as a “Substance Use Battery” to ensure that poly-substance use patterns are not overlooked during intake or routine monitoring.
Yes, the DAST-10 is a rigorously validated, evidence-based instrument with high internal consistency and strong predictive validity across diverse populations. It is recognized by the National Institute on Drug Abuse (NIDA) and is a standard requirement for many state and federal behavioral health reporting protocols in the USA and Australia.
Digital DAST-10 tracking via MyOutcomes automates the calculation of severity scores and instantly alerts clinicians when a client crosses the “high-risk” threshold (Score of 6+). By visualizing substance use trends alongside session-by-session alliance data (SRS), therapists can see if a “spike” in drug-related problems correlates with a rupture in the therapeutic relationship, allowing for more precise and safer clinical interventions.
Explore additional tools for anxiety, trauma, substance use, and child mental health.